137 related articles for article (PubMed ID: 36144393)
21. Whole-genome sequencing reveals high-risk clones of
Zhao Y; Chen D; Ji B; Zhang X; Anbo M; Jelsbak L
Front Microbiol; 2023; 14():1117017. PubMed ID: 37125174
[TBL] [Abstract][Full Text] [Related]
22. Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care-associated infection control in the hospitals of Southern China: a case-control surveillance study.
Peng Y; Bi J; Shi J; Li Y; Ye X; Chen X; Yao Z
Am J Infect Control; 2014 Dec; 42(12):1308-11. PubMed ID: 25444305
[TBL] [Abstract][Full Text] [Related]
23. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity.
Paramythiotou E; Lucet JC; Timsit JF; Vanjak D; Paugam-Burtz C; Trouillet JL; Belloc S; Kassis N; Karabinis A; Andremont A
Clin Infect Dis; 2004 Mar; 38(5):670-7. PubMed ID: 14986251
[TBL] [Abstract][Full Text] [Related]
24. Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey.
Del Barrio-Tofiño E; Sánchez-Diener I; Zamorano L; Cortes-Lara S; López-Causapé C; Cabot G; Bou G; Martínez-Martínez L; Oliver A;
J Antimicrob Chemother; 2019 Nov; 74(11):3217-3220. PubMed ID: 31430372
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcomes of multidrug resistant pseudomonas aeruginosa infection and the relationship with type III secretion system in patients with diabetic foot.
Zhang J; Chu Y; Wang P; Ji X; Li X; Wang C; Peng Y
Int J Low Extrem Wounds; 2014 Sep; 13(3):205-10. PubMed ID: 25106442
[TBL] [Abstract][Full Text] [Related]
26. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone.
Pirnay JP; De Vos D; Cochez C; Bilocq F; Pirson J; Struelens M; Duinslaeger L; Cornelis P; Zizi M; Vanderkelen A
J Clin Microbiol; 2003 Mar; 41(3):1192-202. PubMed ID: 12624051
[TBL] [Abstract][Full Text] [Related]
27. Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.
Del Barrio-Tofiño E; Zamorano L; Cortes-Lara S; López-Causapé C; Sánchez-Diener I; Cabot G; Bou G; Martínez-Martínez L; Oliver A;
J Antimicrob Chemother; 2019 Jul; 74(7):1825-1835. PubMed ID: 30989186
[TBL] [Abstract][Full Text] [Related]
28. Correlation between antibiotic resistance and virulence of Pseudomonas aeruginosa clinical isolates.
Sonbol FI; Khalil MA; Mohamed AB; Ali SS
Turk J Med Sci; 2015; 45(3):568-77. PubMed ID: 26281322
[TBL] [Abstract][Full Text] [Related]
29. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update.
Del Barrio-Tofiño E; López-Causapé C; Oliver A
Int J Antimicrob Agents; 2020 Dec; 56(6):106196. PubMed ID: 33045347
[TBL] [Abstract][Full Text] [Related]
30. An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit.
Knoester M; de Boer MG; Maarleveld JJ; Claas EC; Bernards AT; de Jonge E; van Dissel JT; Veldkamp KE
Clin Microbiol Infect; 2014 Apr; 20(4):O207-15. PubMed ID: 24707852
[TBL] [Abstract][Full Text] [Related]
31. Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.
Cabot G; López-Causapé C; Ocampo-Sosa AA; Sommer LM; Domínguez MÁ; Zamorano L; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Plesiat P; Oliver A
Antimicrob Agents Chemother; 2016 Dec; 60(12):7415-7423. PubMed ID: 27736752
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
33. Combining Standard Molecular Typing and Whole Genome Sequencing to Investigate
Magalhães B; Valot B; Abdelbary MMH; Prod'hom G; Greub G; Senn L; Blanc DS
Front Public Health; 2020; 8():3. PubMed ID: 32047733
[No Abstract] [Full Text] [Related]
34. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
[TBL] [Abstract][Full Text] [Related]
35. High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial.
Pérez A; Gato E; Pérez-Llarena J; Fernández-Cuenca F; Gude MJ; Oviaño M; Pachón ME; Garnacho J; González V; Pascual Á; Cisneros JM; Bou G
J Antimicrob Chemother; 2019 May; 74(5):1244-1252. PubMed ID: 30753505
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial Resistance and Genomic Characterization of Six New Sequence Types in Multidrug-Resistant
Irum S; Naz K; Ullah N; Mustafa Z; Ali A; Arslan M; Khalid K; Andleeb S
Antibiotics (Basel); 2021 Nov; 10(11):. PubMed ID: 34827324
[No Abstract] [Full Text] [Related]
37. Risk factors for community-associated multidrug-resistant Pseudomonas aeruginosa in veterans with spinal cord injury and disorder: a retrospective cohort study.
Kale IO; Fitzpatrick MA; Suda KJ; Burns SP; Poggensee L; Ramanathan S; Sabzwari R; Evans CT
Spinal Cord; 2017 Jul; 55(7):687-691. PubMed ID: 28169292
[TBL] [Abstract][Full Text] [Related]
38. Local outbreak of extended-spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 high-risk clone.
Royer G; Fourreau F; Boulanger B; Mercier-Darty M; Ducellier D; Cizeau F; Potron A; Podglajen I; Mongardon N; Decousser JW
J Hosp Infect; 2020 Jan; 104(1):33-39. PubMed ID: 31369808
[TBL] [Abstract][Full Text] [Related]
39. Molecular Epidemiology of Carbapenemase-Producing
Ohadian Moghadam S; Afshar D; Nowroozi MR; Behnamfar A; Farzin A
Infect Drug Resist; 2020; 13():1583-1592. PubMed ID: 32581561
[TBL] [Abstract][Full Text] [Related]
40. bla
Aruhomukama D; Najjuka CF; Kajumbula H; Okee M; Mboowa G; Sserwadda I; Mayanja R; Joloba ML; Kateete DP
BMC Infect Dis; 2019 Oct; 19(1):853. PubMed ID: 31619192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
